SEC Form 4 · accession 0001209191-16-138444
REATA PHARMACEUTICALS INC · RETA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack Nielsen
Director
Period of report
Aug 22, 2016
Accepted (ET)
Aug 24, 2016 · 3:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A common stock | Aug 22, 2016 | P | 1,780 | $17.00 | A | 1,780 | D |
Table II — derivative securities
No Table II lines on this filing.